Skip to content

Survivor mHealth: Wearable Devices in Cancer Survivors

Survivor mHealth: Assessing Feasibility of a Wearable Device and App in Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05417438
Enrollment
31
Registered
2022-06-14
Start date
2023-01-15
Completion date
2023-10-15
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cardiovascular Diseases

Keywords

Physical activity, Wearable, Communication

Brief summary

The Survivor mobile health (mHealth) study is testing the use of wearable devices (Fitbits) and a smartphone application in cancer survivors. The goal of the program is to increase survivor's physical activity levels. The Fitbit will be synced to the app and participants will receive messages and notifications about their activity levels. Participants will also complete surveys through the app asking how useful it is and ways to improve it. The study team will conduct qualitative interviews at the completion of the 3 months to see how participants liked the program, and ways it can be improved and make it more specific to cancer survivors. The study team will also conduct interviews with providers and clinic staff to assess their perceptions of patient digital health programs and preferences for receiving patient-generated health data.

Interventions

BEHAVIORALWearable device deployment

Participants will receive a Fitbit to be synced with a smartphone app (MyDataHelps). Participants will receive push notifications to complete surveys via the MyDataHelps app. The Fitbit will sync with the app for data collection.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

Aims 1 and 2 Inclusion Criteria: 1. Past cancer diagnosis 2. At least 18 years of age 3. Capacity to provide informed consent 4. Medically cleared to perform physical activity (as noted by Physical Activity Readiness Questionnaire form or physician's clearance if needed) 5. Owns a smartphone Aims 1 and 2

Exclusion criteria

1. Is a prisoner 2. Non-English speaking 3. Is unable to provide consent 4. Under 18 years of age 5. No prior cancer diagnosis 6. Does not own a smartphone Aim 3 Inclusion Criteria: 1. Are a current UMass Memorial Cancer Clinic patient navigator, oncologist, radiologist, or cardiologist 2. Consent to participate Aim 3

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of EnrollmentBaselineFeasibility will be determined by a participant meeting all three criteria: 1) Enrollment in trial, 2) completion of baseline measures, and 3) Fitbit sync to app.

Secondary

MeasureTime frameDescription
3-month Daily Step CountAt study completion, within 3-months of enrollmentThe mean number of steps taken per day during week 12 of the intervention.
1-Month Usability Overall APP Rating1-month post-enrollmentMobile Application Rating Scale (MARS). The Rating scale assesses app quality on four dimensions. All items are rated on a 5-point scale from 1.Inadequate to 5.Excellent. The mean was taken from the overall app usability question and reported. A higher score indicates greater user acceptability of the app. The lowest possible score is a 1, and the highest possible score is a 5.

Countries

United States

Participant flow

Participants by arm

ArmCount
Wearable Device Deployment
Participants will be enrolled in the experimental trial to receive Fitbits and a smartphone app. Wearable device deployment: Participants will receive a Fitbit to be synced with a smartphone app (MyDataHelps). Participants will receive push notifications to complete surveys via the MyDataHelps app. The Fitbit will sync with the app for data collection.
31
Total31

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicWearable Device Deployment
Age, Continuous64.7 years
STANDARD_DEVIATION 11.1
Annual Household income
<$25,000
2 Participants
Annual Household income
$25,000 to $50,000
5 Participants
Annual Household income
$50,001 to $75,000
4 Participants
Annual Household income
>$75,000
18 Participants
Annual Household income
Unknown
2 Participants
Cancer type
Blood
2 Participants
Cancer type
Breast
4 Participants
Cancer type
Colon
1 Participants
Cancer type
Gynecologic
2 Participants
Cancer type
Kidney
1 Participants
Cancer type
Prostate
9 Participants
Cancer type
Skin
2 Participants
Cancer type
Throat
2 Participants
Cancer type
Thyroid
2 Participants
Cancer type
Unknown
6 Participants
Education level
Advanced college degree
11 Participants
Education level
Bachelor's degree
6 Participants
Education level
High school or less
7 Participants
Education level
Some college
7 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
24 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
20 Participants
Region of Enrollment
United States
31 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
0 / 31
serious
Total, serious adverse events
0 / 31

Outcome results

Primary

Feasibility of Enrollment

Feasibility will be determined by a participant meeting all three criteria: 1) Enrollment in trial, 2) completion of baseline measures, and 3) Fitbit sync to app.

Time frame: Baseline

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Wearable Device DeploymentFeasibility of Enrollment30 Participants
Secondary

1-Month Usability Overall APP Rating

Mobile Application Rating Scale (MARS). The Rating scale assesses app quality on four dimensions. All items are rated on a 5-point scale from 1.Inadequate to 5.Excellent. The mean was taken from the overall app usability question and reported. A higher score indicates greater user acceptability of the app. The lowest possible score is a 1, and the highest possible score is a 5.

Time frame: 1-month post-enrollment

Population: Completed 1-month usability survey.

ArmMeasureValue (MEAN)Dispersion
Wearable Device Deployment1-Month Usability Overall APP Rating3.79 units on a scaleStandard Deviation 0.82
Secondary

3-month Daily Step Count

The mean number of steps taken per day during week 12 of the intervention.

Time frame: At study completion, within 3-months of enrollment

Population: Number of participants with validated wear-time.

ArmMeasureValue (MEAN)Dispersion
Wearable Device Deployment3-month Daily Step Count6687 Steps/dayStandard Deviation 3183

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026